Search

everythinglearnresearchcommunity

for

Search:↓

IGF-1 affects hair loss and could be a potential treatment.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

Melatonin affects mouse skin and may regulate skin functions.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Desmoglein 3 organization in cell connections changes without calcium, affecting cell adhesion.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Wnt signaling controls whether hair follicle stem cells stay inactive or regenerate hair.

Fibromodulin might help reduce scarring if increased in adult wounds like in fetal skin that heals without scars.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Fetal skin cells from a cell bank heal wounds faster and with less scarring than adult cells.

High-frequency ultrasonography is a useful but underused tool in dermatology for assessing skin cancers, monitoring diseases, and evaluating treatments.

Sebaceous glands in the skin play a key role in absorbing the antiandrogen drug RU 58841, especially when it's encapsulated in liposomes.